Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Supplemental materials for: Morgan et al

Files in this Data Supplement:

• Figure S1. OS in patients according to treatment group: landmark analysis at 18 months (JPG, 52.2 KB) -
  (A) Patients with favorable cytogenetic profiles and (B) adverse cytogenetic profiles.